Notice: This company has been marked as potentially delisted and may not be actively trading. Recro Pharma (REPH) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Fuji Pharma Co. Ltd.January 30, 2024 | wsj.comHere's what Wall Street expects from Recro Pharma's earnings reportNovember 7, 2023 | markets.businessinsider.comUS supreme court halts Purdue Pharma deal that shields Sacklers from lawsuitsAugust 16, 2023 | theguardian.comWhat Wall Street expects from Recro Pharma's earningsAugust 9, 2023 | markets.businessinsider.comMankind Pharma Ltd (MNKI)August 3, 2023 | investing.comBaudax Bio acquires Maryland biotechnology firm TeraImmune; stock jumpsJune 30, 2023 | bizjournals.comPomerantz LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of Recro Pharma, Inc. Common Stock – SCTLJune 24, 2022 | benzinga.comSocietal CDMO IncApril 20, 2022 | reuters.comRecro Pharma, Inc.: Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and TransformationMarch 22, 2022 | finanznachrichten.deIs Recro Pharma (REPH) a Worthy Investment?March 22, 2022 | finance.yahoo.comRecro Pharma (NASDAQ:REPH) Coverage Initiated by Analysts at StockNews.comStockNews.com initiated coverage on shares of Recro Pharma in a research report on Friday. They set a "hold" rating on the stock.March 18, 2022 | marketbeat.comRecro Pharma (NASDAQ:REPH) Coverage Initiated by Analysts at StockNews.comStockNews.com assumed coverage on shares of Recro Pharma in a research report on Wednesday. They set a "hold" rating for the company.March 2, 2022 | marketbeat.comRecap: Recro Pharma Q4 EarningsMarch 1, 2022 | benzinga.comRecro Reports Progress Towards Launching Fill/Finish and Lyophilization Capabilities at San Diego FacilityFebruary 23, 2022 | finance.yahoo.comRecro to Report Financial Results for Fourth Quarter and Year-end 2021 on March 1, 2022February 22, 2022 | finance.yahoo.comRecro Wins $1.5 Million Formulation Development and CGMP Manufacturing Contract to Support Clinical Development of Topical Treatment for Skin Cancer PreventionJanuary 26, 2022 | finance.yahoo.comRecro Pharma (NASDAQ:REPH) Downgraded by Zacks Investment ResearchZacks Investment Research cut shares of Recro Pharma from a "hold" rating to a "sell" rating in a research report on Thursday.January 6, 2022 | marketbeat.comRecro to Present at H.C. Wainwright BioConnect 2022 ConferenceJanuary 3, 2022 | finance.yahoo.comDo Options Traders Know Something About Recro Pharma (REPH) Stock We Don't?December 8, 2021 | finance.yahoo.comRecro Pharma (NASDAQ:REPH) Cut to "Hold" at Zacks Investment ResearchZacks Investment Research cut shares of Recro Pharma from a "buy" rating to a "hold" rating in a research note on Wednesday.December 8, 2021 | marketbeat.comRecro to Report Financial Results for Third Quarter 2021 on November 9, 2021November 2, 2021 | finance.yahoo.comRecro Enters Into Master Commercial Supply and Services Agreement With OtsukaOctober 27, 2021 | finance.yahoo.comRecro Pharma Signs Renewable Energy Agreement with Georgia PowerSeptember 21, 2021 | marketwatch.comRecro Signs Renewable Energy Agreement With Georgia PowerSeptember 21, 2021 | finance.yahoo.comRecro Pharma (REPH) Moves to Buy: Rationale Behind the UpgradeSeptember 16, 2021 | finance.yahoo.comRecro Pharma goes bicoastal with 'transformative' acquisition of San Diego firm for $50MAugust 16, 2021 | bizjournals.comRecro Pharma Buys San Diego-Based Irisys for $50 Million >REPHAugust 13, 2021 | marketwatch.comRecro Announces Acquisition of San Diego-based IRISYS, Creating Bi-Coastal, Full Service CDMOAugust 13, 2021 | finance.yahoo.comRecro Announces Entry Into Letter of Intent for Acquisition of a Full Service CDMOAugust 10, 2021 | finance.yahoo.comRecro Pharma is about to announce its earnings — here's what to expectAugust 7, 2021 | markets.businessinsider.comRecro Pharma Inc hosts conference call for investorsAugust 6, 2021 | markets.businessinsider.comRecro To Report Financial Results for Second Quarter 2021 on August 9, 2021August 2, 2021 | finance.yahoo.com Get Recro Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for REPH and its competitors with MarketBeat's FREE daily newsletter. Email Address A “Thank You Gift” From Pres. Trump - Genius (Ad)Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics… Get Your Free Gold Guide REPH Media Mentions By Week REPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. REPH News Sentiment▼0.000.55▲Average Medical News Sentiment REPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. REPH Articles This Week▼00▲REPH Articles Average Week Get Recro Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for REPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Theravance Biopharma News Rigel Pharmaceuticals News Xeris Biopharma News Verve Therapeutics News Foghorn Therapeutics News Alumis News Aquestive Therapeutics News KalVista Pharmaceuticals News Tango Therapeutics News Akebia Therapeutics News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:REPH) was last updated on 11/26/2024 by MarketBeat.com Staff From Our PartnersA “Thank You Gift” From Pres. Trump - GeniusTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThis Crisis Could Be Worse Than 2008Underneath the surface, cracks are forming. Cracks that threaten to shatter everything we know. America ...Behind the Markets | SponsoredIs NVDA a sell? Buy this stock instead before Dec 3After months of speculation that Nvidia was "cooling off..." and "running out of steam..." The company is m...Chaikin Analytics | Sponsored140% Yields From Stocks Like Tesla? Here's How (Black Friday Special)140% Dividends from stocks like Tesla? Discover How for Just $9! For Black Friday, get the full details of ...Investors Alley | Sponsored9 hidden AI stocks set to thrive in Trump’s new eraAI ETFs are Booming, But These 9 AI Stocks are Better Plays By 2030, the AI industry is projected to be wor...StockEarnings | SponsoredThe Biggest Post-Election Market Shift Ever?Our No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Recro Pharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Recro Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
